Stocks

Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Global Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q1 2025, the MSCI World Index decreased by 1.8%, driven by the decline of …

Highlights Awale continues to deliver high-grade results from its Odienne project, including 16.4 g/t gold over 52 metres at Charger. Awale welcomed Fortuna Mining with a +$8 million strategic investment. American Eagle announced another investment by South32 and commenced its 30,000 metre drill program …

Diamond drilling has commenced at the road accessible GC target Over $700,000 received through the exercise of share purchase warrants VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Trifecta Gold Ltd. (TSXV:TG)(OTCQB:TRRFF) ("Trifecta" or the "Company") is pleased to announce that drilling …

Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced the approval of a novel formulation of the first-of-its-kind, ready-to-infuse formulation of vancomycin, under the brand name TYZAVAN™ (Vancomycin …

Bakery giant Greggs has warned that the recent heatwave led to shoppers buying fewer pastries, resulting in a sharp drop in the company’s share price. In an update to investors, Greggs said “very high temperatures” triggered a reduction in footfall across its stores, with …

Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - Compass Gold Corp. (TSXV: CVB) ("Compass" or the "Company") announced today that the holders of outstanding convertible debentures of the Company due June 30, 2025 (the "Convertible Debentures") have agreed to convert 93% the aggregate principal …

Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing data and outlines key terms for a future …